Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note
-
Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo’s Senior Secured Convertible Note
-
Oncolytics Biotech® to Participate in a Fireside Chat at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Form 8.3 - [CareTech Holdings plc - 11 04 2022] - (CGWL)
-
Silver Range Resources Ltd. Closes Private Placement and Provides Exploration Update
-
Proactive news headlines including Milestone Scientific, Trust Stamp, Argentina Lithium & Energy, SoLVBL Solutions, AIM ImmunoTech and Blue Sky Uranium
-
Proactive news headlines including Milestone Scientific, Trust Stamp, Argentina Lithium & Energy, SoLVBL Solutions, AIM ImmunoTech and Blue Sky Uranium
-
Pivotal and GFI Announce Private Placement Offering of Subscription Receipts by GFI
-
Qualtrics (XM) Moat is Evolving, Management Mtg Highlights Evolution - Canaccord Genuity
-
Canaccord Genuity Reinstates Ardent Leisure Group Ltd (ALG:AU) (ARDLF) at Hold
-
ValOre Launches Strategic Review of Asset Portfolio
-
RMR Science Technologies Inc. Provides Update on Proposed Business Combination with Turnium Technology Group, Inc.
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Atreca to Present at Upcoming Virtual Investor Conferences
-
Delcath Systems to Participate in the Canaccord Genuity Horizons in Oncology Conference
-
Form 8.3 - [CareTech Holdings plc - 07 04 2022] - (CGWL)
-
Grizzly Receives Warrant and Option Exercises and Provides Additional Information Regarding Private Placement on March 24, 2022
-
Black Diamond Therapeutics to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Black Diamond Therapeutics to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
-
Ninepoint Partners Announces Third and Final Closing of Ninepoint 2022 Flow-Through Limited Partnership
-
Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference
-
Neoleukin Therapeutics to Present at Canaccord Genuity Horizons in Oncology Conference
-
BioXcel Therapeutics (BTAI) PT Raised to $84 at Canaccord Genuity
-
Canaccord Genuity Upgrades Hurricane Energy (HUR:LN) (HRCXF) to Hold
-
Canaccord Genuity Upgrades Superior Plus Corp (SPB:CN) (SUUIF) to Buy
-
Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
-
Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
-
Karyopharm to Participate at the Canaccord Genuity Horizons in Oncology Conference
-
Nuvalent to Participate in the 2022 Canaccord Genuity Horizons in Oncology Virtual Conference
-
Selecta Biosciences (SELB) Prices 27.43M Share Offering at $1.41/sh
-
Atalaya Mining PLC Announces Shareholder Update
-
Selecta Biosciences Announces $38.7 Million Underwritten Offering
-
Zedcor Inc. Announces Closing of Brokered Private Placement of Units
-
Tudor Gold Announces Closing of $12.9 Million Brokered Private Placement Offering, with Participation by Eric Sprott
-
Superior Plus Announces Closing of $288 Million Bought Deal Equity Offering
-
Rocket Lab USA (RKLB) Announces Plan to Recover/Reuse Rocket Booster - Canaccord Genuity
-
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
-
1246765 B.C. Ltd. and Lahontan Gold Corp. Announce Closing of Reverse Takeover Transaction
-
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
-
Homology Medicines (FIXX) PT Lowered to $7 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Downgrades Hyzon Motors Inc (HYZN) to Hold
-
CoTec Holdings Corp. Announces Second Closing of Subscription Receipt Financing and TSXV Conditional Approval for Change of Business
-
Music City hosts the 2022 Mid-South ACG Capital Connection
-
Form 8.3 - [CareTech Holdings plc - 04 04 2022] - (CGWL)
-
Angold Announces Closing of $2.74 Million Marketed Public Offering of Units
-
X4 Pharmaceuticals (XFOR) PT Lowered to $10 at Canaccord Genuity
-
Castle Biosciences (CSTL) PT Lowered to $80 at Canaccord Genuity
-
BioNTech (BNTX) PT Lowered to $300 at Canaccord Genuity

